Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

EuroPCR: Resolute trends positively vs. Xience in all-comers trial

Medtronics Resolute zotarolimus-eluting stent was found to be as safe and effective as Abbott Vasculars Xience V everolimus-eluting stent in a predominantly off-label population, based on the results of the RESOLUTE all-comers trial, presented Tuesday by Patrick W. Serruys MD, PhD, at EuroPCR in Paris. Slides

FFR study to assess cost effectiveness, outcomes in EU, Canada

A study, sponsored by St. Jude Medical, will assess the costs and outcomes linked to fractional flow reserve (FFR) interventional strategies for coronary artery disease patients in seven regions.

EuroPCR: Pre-PCI hypothermia for STEMIs reduces infarct size

Inducing hypothermia by a combo infusion of cold saline and use of an endovascular cooling catheter is an effective adjuctive therapy for acute MI patients, according to a study presented Thursday by researchers from Lund University Hospital in Lund, Sweden, at EuroPCR in Paris.

JACC: Pre-hospital tirofiban reduces adverse events for STEMI patients

Pre-hospital administration of a high bolus dose of tirofiban in addition to aspirin, clopidogrel and unfractionated heparin can reduce rates of major adverse cardiac events in STEMI patients after primary PCI is performed, according to a study published May 25 in the Journal of the American College of Cardiology.

Lancet: Fibrates could have preventive role for coronary events

Fibrate drugs have shown that they reduce the risk of major cardiovascular events, mainly through prevention of coronary artery disease and the need for revascularisation events such as angioplasty or PCI, according to a meta-analysis published online May 11 in the Lancet.

SCAI: Cerebral protection device exceeds expectations in carotid stenting

The Mo.Ma proximal cerebral protection device, used in combination with FDA-approved carotid stents in high-surgical risk subjects, resulted in excellent safety and effectiveness outcomes compared with a performance goal derived from previous carotid stenting trials, based on the ARMOUR trial, presented May 6 at the 33rd annual Society for Cardiovascular Angiography and Interventions (SCAI) conference in San Diego. Slides

Circulation: Noncardiac surgery too soon after stenting increases CV events

Risk of in-hospital death and adverse ischemic events rises when noncardiac surgery is performed less than six weeks after stent implantation, no matter the stent type, according to a study published May 4 in Circulation: Cardiovascular Interventions.

SCAI: Round-the-clock cath lab staffing beats 90-minute goal by one-third

San Diego -- An on-site, seven-day, 24-hour interventional cardiologist eliminates longer door-to-balloon times associated with off-hours presentation and reduces mortality in patients who present off hours, according to a study presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd annual scientific sessions.

Displaying 2441 - 2448 of 2683

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.